CSE:LOBE

Lobe Sciences Invites You to Join Us at the Q2 Virtual Investor Summit

Lobe Sciences (CSE: LOBE) today announced that Philip Young, CEO and Director, will be attending the Q2 Virtual Investor Summit.

 Event  Q2 Investor Summit
 Date  May 17-18th, 2021
 Presentation  May 18th at 10:15 AM ET
 Location  https://zoom.us/webinar/register/WN_9O2Bo2GAS-Ks6W5cFJKFWQ

 

About Lobe Sciences

Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

For further information:

Lobe Sciences
Philip Young CEO & Director
(949) 505-5623
info@lobesciences.com

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com.

Contact:

Sasha Murray at sasha@investorsummitgroup.com

News Provided by Newsfile via QuoteMedia

cannabis investingcse:lobe
Lobe Sciences
Sign up to get your FREE

Lobe Sciences Investor Kit

and hear about exciting investment opportunities.
  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Lobe Sciences (CSE:LOBE,OTCQB: LOBEF)

Lobe Sciences

Lobe Sciences
Sign up to get your FREE

Lobe Sciences Investor Kit

and hear about exciting investment opportunities.
  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Entering Clinical Stage Development for Proprietary Patent-pending Psilocin Compounds

Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest News

Lobe Sciences
Sign up to get your FREE

Lobe Sciences Investor Kit

and hear about exciting investment opportunities.
  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units

Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

CSE Bulletin: MOC Eligibility Update

FALCO ANNOUNCES CLOSING OF BOUGHT DEAL PRIVATE PLACEMENT

Related News

Base Metals Investing

Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units

Gold Investing

Top 5 Canadian Mining Stocks This Week: JZR Gold Jumps 113 Percent

Gold Investing

NevGold Discovers “Highest-grade” Antimony Drilled to Date at Nevada Project

Silver Investing

Vince Lanci: Silver's London Liquidity Crisis — What's Happening, What's Next

Gold Investing

What Was the Highest Price for Gold?

silver investing

What Was the Highest Price for Silver?

Base Metals Investing

FALCO ANNOUNCES CLOSING OF BOUGHT DEAL PRIVATE PLACEMENT